Home › Trial NCT02740933
Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors
- Trial IDNCT02740933
- StatusUnknown
- PhasePhase 1
- Study typeInterventional
- SponsorMassachusetts General Hospital
- Enrollment40
- Start date2016-04
- ConditionsBrain Tumor
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.